Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
Robin Hallett(Hospital for Sick Children), John A. Hassell(McMaster University)
Cited by 93
Related Papers
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
|Oncotarget|2017|52
Antagonists of the serotonin receptor 5A target human breast tumor initiating cells
|BMC Cancer|2020|20
Transcript signatures that predict outcome and identify targetable pathways in MYCN‐amplified neuroblastoma
|Molecular Oncology|2016|17